长期使用克洛米芬在男性巨乳腺瘤中,持续患有阴性双胞胎症
Matheo A M Stumpf1, Stefano A Galliano2, Cristina B F Bueno3
1Neuroendocrine Unit, Division of Endocrinology and Metabolism, University of São Paulo Medical School Hospital, São Paulo, Brazil. matheoaugusto@hotmail.com.
Endocrine
|April 5, 2024
概括
克洛米芬酸盐 (CC) 有效地恢复了男性的丸激素水平 巨乳腺瘤和阴道腺缩症. 这项研究表明,CC是一种安全的,长期治疗选择,用于管理这些患者的持续性阴道腺缩症.
科学领域:
- 内分泌学 在内分泌学.
- 生殖医学 生殖医学
背景情况:
- 在患有巨乳腺瘤的男性中,即使在正常化了益生菌度后,也可能发生持续性性阴性腺.
- 替代疗法是标准的,但克洛米芬酸盐 (CC) 是一种非标签的选择,特别是对于生育问题.
研究的目的:
- 为了评估克洛米芬酸盐 (CC) 在恢复雄性腺轴的有效性,在男性与巨乳细胞瘤.
- 为了评估CC的安全性,作为长期治疗持续性阴道腺缩症在这个人群.
主要方法:
- 对10名患有巨乳腺瘤和持续性阴性腺瘤的男性进行了回顾性研究,他们接受了cabergoline.
- 所有患者都接受了50毫克/天克洛米芬酸盐 (CC) 的初始剂量.
主要成果:
- 在平均3.2年的CC疗程期间,水平显著增加 (p=0.027).
- 80%的患者有反应,维持丸激素在300ng/dL以上;瘤大小保持稳定.
- 在CC治疗期间没有报告任何不良反应或安全问题.
结论:
- 克洛米芬酸盐 (CC) 是一种安全有效的治疗方法,用于治疗患有巨细胞巨瘤的男性持续性阴性双胞胎症.
- 在这种患者群体中,CC提供了一种可行的治疗选择,用于管理这种患者群体的阴道腺症.
相关概念视频
Infertility in Males
261
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
261
Infertility in Females
292
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
292


